Brief: Aurinia Underscores Enduring Commitment To People Living With Lupus Nephritis Through Innovative Advocacy And Education Initiatives
01/05/2024 11:09
May 1 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O :
* AURINIA UNDERSCORES ENDURING COMMITMENT TO PEOPLE LIVING
WITH
LUPUS NEPHRITIS THROUGH INNOVATIVE ADVOCACY AND EDUCATION
INITIATIVES FOR LUPUS AWARENESS MONTH
Source text for Eikon: ID:nBw9YtBjNa
Further company coverage: AUPH.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death